{"id":3140,"date":"2022-11-04T10:58:14","date_gmt":"2022-11-04T09:58:14","guid":{"rendered":"https:\/\/www.celltrend.de\/?p=3140"},"modified":"2022-11-04T10:58:57","modified_gmt":"2022-11-04T09:58:57","slug":"apheresis-against-long-covid","status":"publish","type":"post","link":"https:\/\/www.celltrend.de\/en\/apheresis-against-long-covid\/","title":{"rendered":"Apheresis against Long-COVID?"},"content":{"rendered":"<p>According to the congress report of the 14th annual meeting of the German Society of Nephrology, ten patients with severe ME\/CFS underwent immunapheresis. In 7 out of 10 patients this leads to a significant improvement in symptoms. Prof. Dr. Scheibenbogen suspects an apheresis effect on the beta cell compartment, because autoantibodies against \u00df1 and \u00df2 receptors are significantly reduced.<br \/>\nA study, which is currently underway at the Charit\u00e9, aims to clarify whether long-COVID patients also benefit from apheresis therapy. The titer of the anti-\u00df receptors serves as an indicator for this.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>According to the congress report of the 14th annual meeting of the German Society of Nephrology, ten patients with severe ME\/CFS underwent immunapheresis. In 7 out of 10 patients this leads to a significant improvement in symptoms. Prof. Dr. Scheibenbogen suspects an apheresis effect on the beta cell compartment, because autoantibodies against \u00df1 and \u00df2&hellip;<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[9],"tags":[],"yst_prominent_words":[175,479,641,394,446,615,472],"class_list":["post-3140","post","type-post","status-publish","format-standard","hentry","category-news-en","category-9","description-off"],"_links":{"self":[{"href":"https:\/\/www.celltrend.de\/en\/wp-json\/wp\/v2\/posts\/3140","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.celltrend.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.celltrend.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.celltrend.de\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.celltrend.de\/en\/wp-json\/wp\/v2\/comments?post=3140"}],"version-history":[{"count":1,"href":"https:\/\/www.celltrend.de\/en\/wp-json\/wp\/v2\/posts\/3140\/revisions"}],"predecessor-version":[{"id":3141,"href":"https:\/\/www.celltrend.de\/en\/wp-json\/wp\/v2\/posts\/3140\/revisions\/3141"}],"wp:attachment":[{"href":"https:\/\/www.celltrend.de\/en\/wp-json\/wp\/v2\/media?parent=3140"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.celltrend.de\/en\/wp-json\/wp\/v2\/categories?post=3140"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.celltrend.de\/en\/wp-json\/wp\/v2\/tags?post=3140"},{"taxonomy":"yst_prominent_words","embeddable":true,"href":"https:\/\/www.celltrend.de\/en\/wp-json\/wp\/v2\/yst_prominent_words?post=3140"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}